FDA Recall: Prednisolone Acetate Eye Drops Recalled Due to Potential Contamination
More than 2 million bottles of prescription Prednisolone Acetate Ophthalmic Suspension eye drops have been voluntarily recalled across the United States due to the possibility that a foreign substance is in the product. According to the U.S.
Understanding the FDA Enforcement Report and Recall Classification
The FDA formalized the safety action by issuing an enforcement report giving the recall a Class II classification. According to goodhousekeeping.com, a Class II recall means that if you use or are exposed to a recalled product, you could suffer temporary, treatable health problems that are probably not serious in the long run. Patients are urged to verify their medication packaging immediately.
The recalled medication is officially labeled as prednisoLONE Acetate Ophthalmic Suspension, USP, 1%, and is strictly available by prescription only as a sterile product. According to the Mayo Clinic, these specific ophthalmic drops are used to relieve redness, itching, and swelling caused by eye infections and other conditions.
Affected Product Details, National Drug Codes, and Lot Numbers
The nationwide recall impacts three distinct bottle sizes: 5 mL, 10 mL, and 15 mL configurations. Each size corresponds to a specific National Drug Code (NDC) identifier printed directly on the product label. Identifying these codes is the primary step for patients inspecting their home medicine cabinets.
The specific NDC numbers associated with the recalled inventory include:
- 5 mL bottles: NDC 70748-332-02
- 10 mL bottles: NDC 70748-332-03
- 15 mL bottles: NDC 70748-332-04
According to safety data published by Good Housekeeping, the affected lots span expiration dates reaching from July 2026 through March 2028. For example, 5 mL bottles expiring on July 31, 2026, include lot numbers HA00937, HA00939, HA00941, HA00971, HA00973, and HA00975. Later lots expiring on March 31, 2028, feature codes such as HC00091. Consumers utilizing 10 mL configurations must check for lots such as HA00945, HA00947, and HA00949, while 15 mL users must verify lots including HA00951, HA00953, and HA00955.
Patient Guidance and Healthcare Consultations
Finding a contaminated medication in a home supply requires prompt, measured action. Patients who discover they possess an impacted batch should stop using the product immediately. Discarding or returning the medication safely prevents accidental exposure to foreign particulate matter.
Healthcare providers play a vital role in helping patients transition to safe therapeutic alternatives without interrupting critical ophthalmic care. Anyone who believes they have used a recalled bottle should contact their prescribing physician immediately to evaluate symptoms and discuss obtaining a safe replacement prescription.